Perfil
Sean McAuliffe is currently the Chief Business Officer at Taysha Gene Therapies, Inc. Prior to his current position, he served as the Vice President-Marketing at Novartis Gene Therapies, Inc. from 2018 to 2020.
Cargos activos de Sean McAuliffe
| Empresas | Cargo | Inicio |
|---|---|---|
| TAYSHA GENE THERAPIES, INC. | Corporate Officer/Principal | 01/06/2020 |
Antiguos cargos conocidos de Sean McAuliffe.
| Empresas | Cargo | Fin |
|---|---|---|
| AVEXIS INC | Ventas & Marketing | 01/06/2020 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| TAYSHA GENE THERAPIES, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Bolsa de valores
- Insiders
- Sean McAuliffe